Carl Zeiss Meditec (AFX) PT Set at €80.00 by Deutsche Bank

Deutsche Bank set a €80.00 ($93.02) price target on Carl Zeiss Meditec (ETR:AFX) in a research report report published on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

AFX has been the subject of several other research reports. Berenberg Bank set a €68.00 ($79.07) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Monday, February 11th. Hauck & Aufhaeuser set a €92.50 ($107.56) target price on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research report on Monday, April 15th. Nord/LB set a €92.00 ($106.98) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Wednesday, May 8th. Independent Research set a €76.50 ($88.95) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Monday, April 15th. Finally, HSBC set a €78.00 ($90.70) target price on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Monday, April 8th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. Carl Zeiss Meditec currently has an average rating of Hold and a consensus target price of €78.25 ($90.99).

AFX opened at €88.55 ($102.97) on Friday. The stock has a market capitalization of $7.92 billion and a PE ratio of 61.75. Carl Zeiss Meditec has a 1-year low of €56.90 ($66.16) and a 1-year high of €90.60 ($105.35). The company has a quick ratio of 3.09, a current ratio of 4.11 and a debt-to-equity ratio of 4.55.



Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Story: Moving Average Convergence Divergence (MACD)

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.